Stockreport

Nanobiotix H2 Earnings Call Highlights [Yahoo! Finance]

Nanobiotix S.A. - ADSs  (NBTX) 
PDF NBTXR3 program, with the Phase III NANORAY-312 head-and-neck readout expected in H1 2027 and the randomized Phase II CONVERGE lung trial readout expected in early 2027 a [Read more]